Title: Research Communications of the 27(th) ECVIM-CA Congress: Intercontinental, Saint Julian's, Malta, 14th to 16th September 2017 Document date: 2017_11_7
ID: roslkxeq_167
Snippet: Median survival time was 63.6 AE 9.4 months. In the univariate analysis, significant prognostic factors were tumor volume in cm 3 (P = 0.015, hazard ratio (HR) = 1.004), maximal diameter of tumor in cm (P = 0.047, HR = 1.284), Ki67 labeling index (P < 0.001, HR = 1.220) and mRNA expressions of SF-1 (P = 0.021, HR = 60.244), PTTG1 (P = 0.024, HR = 12.321), PBX1 (P = 0.005, HR = 8.714), and TOP2A (P = 0.035, HR = 7.191). Forward stepwise multivaria.....
Document: Median survival time was 63.6 AE 9.4 months. In the univariate analysis, significant prognostic factors were tumor volume in cm 3 (P = 0.015, hazard ratio (HR) = 1.004), maximal diameter of tumor in cm (P = 0.047, HR = 1.284), Ki67 labeling index (P < 0.001, HR = 1.220) and mRNA expressions of SF-1 (P = 0.021, HR = 60.244), PTTG1 (P = 0.024, HR = 12.321), PBX1 (P = 0.005, HR = 8.714), and TOP2A (P = 0.035, HR = 7.191). Forward stepwise multivariate analysis identified Ki67 labeling index (P = 0.024, HR = 1.574) and SF-1 mRNA expression (P = 0.044, HR = 1.936*10 6 ) as independent predictors of poor survival.
Search related documents:
Co phrase search for related documents- multivariate analysis and prognostic factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- multivariate analysis and significant prognostic factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- poor survival and prognostic factor: 1, 2, 3, 4, 5, 6, 7, 8, 9
- poor survival and stepwise multivariate analysis: 1
- poor survival and survival time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- poor survival and tumor volume: 1
- poor survival and univariate analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9
- prognostic factor and significant prognostic factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- prognostic factor and survival time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- prognostic factor and tumor volume: 1, 2, 3, 4, 5
- prognostic factor and univariate analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
- significant prognostic factor and survival time: 1, 2, 3
- significant prognostic factor and tumor volume: 1
- significant prognostic factor and univariate analysis: 1, 2, 3, 4, 5, 6
- stepwise multivariate analysis and survival time: 1
- stepwise multivariate analysis and univariate analysis: 1, 2, 3, 4, 5, 6, 7
- survival time and tumor volume: 1, 2, 3, 4, 5, 6
- survival time and univariate analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- tumor volume and univariate analysis: 1, 2
Co phrase search for related documents, hyperlinks ordered by date